Follow-up of Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy by Electronic Patient Reported Outcomes-tool

Oulu University Hospital

Status: Completed

Conditions: Cancer

Treatments: Device: Electronic patient reported outcomes

Study type: Interventional

Funder types: Other

Identifiers

NCT03928938

9/2017

Details and patient eligibility

About

Electronic patient reported outcome (ePRO) tools have improved survival and quality of life (QoL) of cancer patients receiving chemotherapy, and in the follow-up of lung cancer patients. Current study investigates electronic patient reported outcome tool in the follow-up of cancer patients receiving immune checkpoint inhibitor therapy.

Current study aims to evaluate 1) patient reported symptoms and their severity, 2) Number of triggered alerts by the tool and their correlation to treatment side-effects, cancer progression, other medical events or survival, 3) Correlation between different symptoms and the correlation of symptoms to treatment side-effects, cancer progression, other medical events or survival,4) QoL of patients and correlation of changes in QoL to treatment side-effects, cancer progression, other medical events or survival, 5) Patient compliance, 6) Correlation of baseline laboratory values to treatment side-effects, cancer progression, other medical events or survival.

Full description

Please see the Brief summary

Enrollment: 43 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Signed informed consent
2. Advanced cancers
3. Immune checkpoint inhibitor therapy initiated within +/- 2wks
4. Age >18y
5. ECOG 0-3
6. Patient compliant with the study procedures

Exclusion criteria

1. Immune checkpoint inhibitor therapy initiated > 2wks ago
2. General vulnerability affecting the participation in the trial
3. No internet access

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

43 participants in 1 patient group

Electronic follow-up

Experimental group

Description:

Follow-up of cancer patients treated with immune checkpoint inhibitor therapy using electronic patient reported outcomes-tool

Treatment:

Device: Electronic patient reported outcomes